Komori
Monthly4880CellSource Co.,Ltd.Pharmaceuticals

Preliminary July Monthly KPI Results for the Fiscal Year Ending October 2026

The average number of contract processing orders in July 2026 was 57.1 per day, exceeding the level in the same month of the previous year. By category, orders from hybrid orthopedic clinics increased, while those from self-pay treatment-focused orthopedic clinics and obstetrics and gynecology clinics declined.

Worth reading
58In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
57.1
orders/day
Wording
Conditional
How definitive the wording is.

Sales for this month

July 2026Fiscal year ending October 2026
Year-on-year change by component
Obstetrics and gynecology clinics
-139.5%
Self-pay orthopedic clinics
-106.9%
Cosmetic medicine
-81.2%
Hybrid orthopedic clinics
-74.3%
The bars use a logarithmic scale. This allows the relative sizes of the other items to be read even when one item is much larger than the others.
Key KPI year-on-year change
Number of blood-derived contract processing orders from obstetrics and gynecology clinics
-139.5%
Number of blood-derived processing orders accepted from self-pay orthopedic clinics
-106.9%
Number of blood-derived contract processing orders for aesthetic medicine
-81.2%
Number of blood-derived processing orders accepted from hybrid orthopedic clinics
-74.3%
Monthly Commentary

The average daily number of contract processing orders in July was 57.1, above the same month of the previous year. By medical specialty, orders from hybrid orthopedic clinics increased, posting a new fiscal-year high for year-on-year growth.

Factors Affecting the Change

Effect of measures to promote usage among hybrid orthopedic clinics, Contribution from the KPI strategy revamped from the current fiscal year, Orders from self-pay treatment-focused orthopedic clinics declined year on year despite continued efforts to strengthen the operating structure through the management support business for medical corporations, A decline of 51 orders from obstetrics and gynecology clinics

Measures from the following month onward

Expand the long-term order base among hybrid orthopedic clinics, Continue strengthening the operating structure for self-pay treatment-focused orthopedic clinics

Scope of aggregation: CellSource Co.,Ltd.'s contract processing services

Sales for this month
ItemDetails
Month CoveredJuly 2026
Fiscal Year CoveredFiscal year ending October 2026
Scope of aggregationCellSource Co.,Ltd.'s contract processing services
Year-on-year change by categoryName Self-pay orthopedic clinics / Year on year -6.9 %, Name Hybrid orthopedic clinics / Year on year 25.7 %, Name Obstetrics and gynecology clinics / Year on year -39.5 %, Name Cosmetic medicine / Year on year 18.8 %
Key KPIsIndicator name Average number of processing orders accepted per day / Value 57.1 Engagements / Year on year Above the same month of the previous year, Indicator name Number of blood-derived processing orders accepted from self-pay orthopedic clinics / Value 773 Engagements / Year on year -6.9 Engagements, Indicator name Number of blood-derived processing orders accepted from hybrid orthopedic clinics / Value 808 Engagements / Year on year 25.7 Engagements, Indicator name Number of blood-derived contract processing orders from obstetrics and gynecology clinics / Value Not disclosed / Year on year -39.5 Engagements, Indicator name Number of blood-derived contract processing orders for aesthetic medicine / Value Not disclosed / Year on year 18.8 Engagements, Indicator name Number of orders from hybrid medical institutions / Value 6,707 Engagements / Year on year Increased, Indicator name Number of Group 1 orders / Value Not disclosed / Year on year Down 253 orders, Indicator name Number of Group 2 orders / Value 1,030 Engagements / Year on year Up 1,030 orders
Monthly CommentaryThe average daily number of contract processing orders in July was 57.1, above the same month of the previous year. By medical specialty, orders from hybrid orthopedic clinics increased, posting a new fiscal-year high for year-on-year growth.
Factors Affecting the ChangeEffect of measures to promote usage among hybrid orthopedic clinics, Contribution from the KPI strategy revamped from the current fiscal year, Orders from self-pay treatment-focused orthopedic clinics declined year on year despite continued efforts to strengthen the operating structure through the management support business for medical corporations, A decline of 51 orders from obstetrics and gynecology clinics
Measures from the following month onwardExpand the long-term order base among hybrid orthopedic clinics, Continue strengthening the operating structure for self-pay treatment-focused orthopedic clinics
Items this document does not state (14)
Net sales for the monthYear-on-year change in monthly net salesTotal-store sales, year on yearSame-Store Sales, Year on YearYear-on-Year Change in Customer CountYear-on-Year Change in Average Spend per CustomerCumulative Sales from Start of PeriodCumulative Year-on-Year Change from Start of PeriodSales by categoryNumber of Stores at Period-EndNumber of stores opened during the monthNumber of stores closed during the monthMonthly trend for the same period last yearNext Scheduled Disclosure

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Orders from hybrid orthopedic clinics increased as a result of measures to promote utilization. Orders from self-pay treatment-focused orthopedic clinics declined year on year despite the continued strengthening of the operating structure through the management support business for medical corporations. For hybrid medical institutions, the KPI strategy revamped from the current fiscal year contributed to performance.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Preliminary July Monthly KPI Results for the Fiscal Year Ending October 2026 | CellSource Co.,Ltd. (4880) timely disclosure | Komori